Lactobacillus Johnsonii for premature ovarian insufficiency
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests if a probiotic called Lactobacillus Johnsonii can help women with premature ovarian insufficiency. It's a small exploratory study to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 39 years old.
- Your periods have been irregular or stopped for more than 4 months.
- You have had blood tests showing high FSH levels (over 25 IU/L) twice, at least 4 weeks apart.
- You agree to participate and follow the study plan.
- You haven't taken antibiotics, probiotics, or hormone therapy in the last 2 months.
- You don't have any other major health conditions like severe endometriosis or blood clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a Chinese herbal formula called Huanjingjian Decoction to see if it can help women with premature ovarian insufficiency (POI). POI means your ovaries stop working normally before age 40, leading to irregular periods and fertility challenges.
This trial uses your own fat cells (called stromal vascular fraction) to try to improve ovarian function and help you become pregnant if you have premature ovarian insufficiency. It may help restore your egg supply and menstrual cycles.
This research study looks at genetic differences in women who have experienced early menopause or severe irregular periods before age 40, with no known cause. By comparing your genes to women with normal menstrual cycles, researchers hope to understand what causes this condition and potentially develop better treatments.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This trial tests whether an immune-modulating drug can restart ovulation and improve fertility in women whose ovaries stopped working due to autoimmune disease. It is for women ages 18–38 with autoimmune premature ovarian insufficiency and certain antibodies.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.